Arvind Suresh
@arvindsuresh1.bsky.social
IM PGY-2 @UCSF | @GeiselMed '23 | @Dartmouth '19 | Aspiring hematologist/oncologist interested in myeloma #MMsm, cell therapy, med ed & health equity | he/him
How should we choose optimal salvage treatments following BCMA-directed CAR-T therapy in multiple myeloma?
Check out our review article out today summarizing recent studies and our approach to therapy sequencing from our team at @ucsfcancer.bsky.social #MMsm #myeloma
dx.doi.org/10.1080/1750...
Check out our review article out today summarizing recent studies and our approach to therapy sequencing from our team at @ucsfcancer.bsky.social #MMsm #myeloma
dx.doi.org/10.1080/1750...
October 18, 2025 at 2:29 AM
How should we choose optimal salvage treatments following BCMA-directed CAR-T therapy in multiple myeloma?
Check out our review article out today summarizing recent studies and our approach to therapy sequencing from our team at @ucsfcancer.bsky.social #MMsm #myeloma
dx.doi.org/10.1080/1750...
Check out our review article out today summarizing recent studies and our approach to therapy sequencing from our team at @ucsfcancer.bsky.social #MMsm #myeloma
dx.doi.org/10.1080/1750...
I enjoyed working with colleagues and mentors at Dartmouth to create and lead these workshops for medical students and faculty to develop skills in addressing microaggressions and bias in their roles as health care professionals, educators, and leaders. Learn more below👇 @aamctoday.bsky.social
This Geisel SOM at Dartmouth 2-hour, in-person workshop for medical & nursing students, residents, fellows, staff, & faculty teaches communication skills for addressing & responding to implicit bias. #MedEd #Medsky www.mededportal.org/doi/10.15766...
What to Say When It Matters: Communication Skills to Address Implicit Bias Workshop | MedEdPORTAL
Introduction In academic medicine, learners, faculty, and staff commonly experience microaggressions,
which have been linked to multiple negative outcomes (e.g., higher levels of depression,
deteriora...
www.mededportal.org
April 28, 2025 at 4:06 AM
I enjoyed working with colleagues and mentors at Dartmouth to create and lead these workshops for medical students and faculty to develop skills in addressing microaggressions and bias in their roles as health care professionals, educators, and leaders. Learn more below👇 @aamctoday.bsky.social
Reposted by Arvind Suresh
At #Tandem25: @drkomanduri.bsky.social
accepts the ASTCT advocacy award. Congratulations Dr. Komanduri, we commend you for your dedication to advancing our field!
accepts the ASTCT advocacy award. Congratulations Dr. Komanduri, we commend you for your dedication to advancing our field!
February 15, 2025 at 12:31 AM
At #Tandem25: @drkomanduri.bsky.social
accepts the ASTCT advocacy award. Congratulations Dr. Komanduri, we commend you for your dedication to advancing our field!
accepts the ASTCT advocacy award. Congratulations Dr. Komanduri, we commend you for your dedication to advancing our field!
Grateful to Clinical Lymphoma, Myeloma & Leukemia, co-authors, and @ash-hematology.bsky.social for the opportunity to share this research on targeted neurocognitive testing after anti-CD19 and anti-BCMA #CART cell therapy. #lymsm #mmsm
clinical-lymphoma-myeloma-leukemia.com/article/S215...
clinical-lymphoma-myeloma-leukemia.com/article/S215...
December 26, 2024 at 8:03 PM
Grateful to Clinical Lymphoma, Myeloma & Leukemia, co-authors, and @ash-hematology.bsky.social for the opportunity to share this research on targeted neurocognitive testing after anti-CD19 and anti-BCMA #CART cell therapy. #lymsm #mmsm
clinical-lymphoma-myeloma-leukemia.com/article/S215...
clinical-lymphoma-myeloma-leukemia.com/article/S215...